← FDA DRUG APPROVALS

FDA ANDA · ANDA071555

NITROPRESS

Sponsor: ABBOTT

APPLICATION
ANDA071555
TYPE
ANDA
ORIGINAL APPROVAL
1987-11-16
LATEST ACTION
1997-01-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NITROPRESSDiscontinued
SODIUM NITROPRUSSIDE 50MG/VIAL · INJECTABLE · INJECTION

Approval history

1997-01-27Labeling · Supplement 1AP
1992-02-03Labeling · Supplement 3AP
1990-12-07Labeling · Supplement 2AP
1987-11-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →